TR701

· Trius Therapeutics LLC, a subsidiary of Merck & Co.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TR701, covering 2017-08-31 to 2017-08-31. Get the full timeline:

Most recent: Clinical Trial Update: Single and Multiple Ascending Dose Pharmacokinetic Study of TR701 in Healthy Adults [Phase 1]